Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Saved in:

Bibliographic Details
Main Authors:	Holmgaard, Rikke B, Zamarin, Dmitriy, Munn, David H, Wolchok, Jedd D, Allison, James P
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2013
Subjects:	Poster Presentation
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3991256/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-1-S1-P77
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items